{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:59:06Z","timestamp":1780981146849,"version":"3.54.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Breast cancer is the most common malignant tumor worldwide, and its high heterogeneity limits the efficacy of current clinical therapies. R-spondin 2 (RSPO2) expression is closely associated with breast cancer subtypes, but the precise mechanisms by which it drives disease progression, particularly its relationship with ferroptosis, remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      RSPO2 expression was examined in primary breast cancer specimens and in MCF-7 and MDA-MB-231 cell lines. Functional assays, including proliferation, migration, and invasion tests, were performed following RSPO2 overexpression.\n                      <jats:italic>In vivo<\/jats:italic>\n                      tumor growth was assessed using a xenograft mouse model. Mechanistically, immunoprecipitation, ubiquitination assays, RNA sequencing (RNA-seq), RIP-qPCR, mRNA stability assays, and ferroptosis-related measurements (ROS, GSH, MDA, Fe\n                      <jats:sup>2+<\/jats:sup>\n                      ) were employed to identify interacting proteins and downstream targets. Rescue experiments with FSP1 overexpression were conducted to validate pathway specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RSPO2 was consistently downregulated in malignant breast cancer tissues. Restoring RSPO2 expression markedly suppressed cell proliferation, migration, and invasion in vitro and inhibited tumor growth in vivo. Mechanistically, RSPO2 recruited the E3 ubiquitin ligase TRIM21 to promote PTBP1 ubiquitination and proteasomal degradation. RNA-seq and validation assays revealed that PTBP1 bound the 3\u2032UTR of ferroptosis suppressor protein 1 (FSP1) mRNA, enhancing its stability. RSPO2 overexpression reduced PTBP1 levels, leading to decreased FSP1 mRNA stability and expression. Consequently, RSPO2 overexpression triggered ferroptosis, as evidenced by ROS accumulation, GSH depletion, and elevated MDA and Fe\n                      <jats:sup>2+<\/jats:sup>\n                      levels. These effects were effectively reversed by FSP1 overexpression, which also abrogated the RSPO2 induced inhibition of cell proliferation, migration, and invasion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study demonstrates that RSPO2 functions as a tumor suppressor in breast cancer by recruiting TRIM21 to degrade PTBP1, thereby reducing FSP1 mRNA stability and promoting ferroptosis. The RSPO2\/PTBP1\/FSP1 signaling axis is identified for the first time in breast cancer and represents a promising novel therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1813451","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:27:47Z","timestamp":1780979267000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuyun","family":"Jiang","sequence":"first","affiliation":[{"name":"College of Clinical Medicine, Qinghai University","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Qinghai University","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwei","family":"Du","sequence":"additional","affiliation":[{"name":"College of Clinical Medicine, Qinghai University","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The Affiliated Hospital of Qinghai University","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The Affiliated Hospital of Qinghai University","place":["Xining, Qinghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci (PNAS)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02059-y","article-title":"The role of R-spondin proteins in cancer biology","volume":"40","author":"Ter Steege","year":"2021","journal-title":"Oncogene"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apcsb.2023.11.011","article-title":"Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer","volume":"139","author":"Srivastava","year":"2024","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5585","article-title":"R-spondins 2 and 3 are overexpressed in a subset of human colon and breast cancers","volume":"40","author":"Conboy","year":"2021","journal-title":"DNA Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-19-0599","article-title":"R-spondin2 suppresses the progression of hepatocellular carcinoma via MAPK signaling pathway","volume":"18","author":"Zheng","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04905-x","article-title":"PTBP1 as a potential regulator of disease","volume":"479","author":"Yu","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70675","article-title":"PTBP1 and cancer: From RNA regulation to therapeutic potential","volume":"29","author":"Ji","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26823","article-title":"PTBP1 promotes the growth of breast cancer cells through the PTEN\/Akt pathway and autophagy","volume":"233","author":"Wang","year":"2018","journal-title":"J Cell Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.167011","article-title":"USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis","volume":"1870","author":"Gao","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41420-022-01183-2","article-title":"Emerging roles of ferroptosis in cardiovascular diseases","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051943","article-title":"Prognostic biomarkers in breast cancer via multi-omics clustering analysis","volume":"26","author":"Malighetti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-023-00491-1","article-title":"AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1\/PGC-1\u03b1 signaling","volume":"12","author":"Guo","year":"2023","journal-title":"Oncogenesis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102799","article-title":"Metabolic intervention nanoparticles for triple-negative breast cancer therapy via overcoming FSP1-mediated ferroptosis resistance","volume":"11","author":"Yang","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-1412","article-title":"PTBP1 lactylation promotes glioma stem cell maintenance through PFKFB4-driven glycolysis","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1261\/rna.070193.118","article-title":"PTBP1 mRNA isoforms and regulation of their translation","volume":"25","author":"Arake de Tacca","year":"2019","journal-title":"RNA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7554\/elife.11155","article-title":"Polypyrimidine tract binding protein 1 protects mRNAs from recognition by the nonsense-mediated mRNA decay pathway","volume":"5","author":"Ge","year":"2016","journal-title":"Elife"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0118-y","article-title":"RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4\/5\/6","volume":"557","author":"Szenker-Ravi","year":"2018","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.131","article-title":"Clinical value of R-spondins in triple-negative and metaplastic breast cancers","volume":"116","author":"Coussy","year":"2017","journal-title":"Br J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217612","article-title":"SLC7A5\/E2F1\/PTBP1\/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway","volume":"617","author":"Jiang","year":"2025","journal-title":"Cancer Lett"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2023-0467oc","article-title":"FSP1 acts in parallel with GPX4 to inhibit ferroptosis in chronic obstructive pulmonary disease","volume":"72","author":"Yang","year":"2025","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020140","article-title":"RNA binding protein PTBP1 promotes the metastasis of gastric cancer by stabilizing PGK1 mRNA","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.11.020","article-title":"hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA","volume":"27","author":"Cen","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403371R","article-title":"PTBP1 reduces KLF9 mRNA stability and upregulates FUBP1 to promote colorectal cancer stemness and cisplatin resistance","volume":"39","author":"Liang","year":"2025","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s12672-025-04128-0","article-title":"PTBP1 functions as a suppressor of ferroptosis in endometrial carcinoma cells by stabilizing SLC7A11 mRNA","volume":"16","author":"Zhu","year":"2025","journal-title":"Discov Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:27:51Z","timestamp":1780979271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":29,"alternative-id":["10.3389\/fonc.2026.1813451"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1813451","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1813451"}}